- Hong Kong
- /
- Healthcare Services
- /
- SEHK:1419
Human Health Holdings' (HKG:1419) Dividend Will Be Increased To HK$0.03
Human Health Holdings Limited's (HKG:1419) periodic dividend will be increasing on the 5th of January to HK$0.03, with investors receiving 7.1% more than last year's HK$0.028. This takes the annual payment to 3.7% of the current stock price, which is about average for the industry.
Human Health Holdings' Future Dividend Projections Appear Well Covered By Earnings
We like a dividend to be consistent over the long term, so checking whether it is sustainable is important. The last dividend was quite easily covered by Human Health Holdings' earnings. This indicates that a lot of the earnings are being reinvested into the business, with the aim of fueling growth.
Looking forward, EPS could fall by 9.5% if the company can't turn things around from the last few years. Assuming the dividend continues along recent trends, we believe the payout ratio could be 56%, which we are pretty comfortable with and we think is feasible on an earnings basis.
View our latest analysis for Human Health Holdings
Human Health Holdings' Dividend Has Lacked Consistency
Human Health Holdings has been paying dividends for a while, but the track record isn't stellar. Due to this, we are a little bit cautious about the dividend consistency over a full economic cycle. The most recent annual payment of HK$0.03 is about the same as the annual payment 9 years ago. We're glad to see the dividend has risen, but with a limited rate of growth and fluctuations in the payments the total shareholder return may be limited.
Dividend Growth Is Doubtful
With a relatively unstable dividend, it's even more important to evaluate if earnings per share is growing, which could point to a growing dividend in the future. It's not great to see that Human Health Holdings' earnings per share has fallen at approximately 9.5% per year over the past five years. Declining earnings will inevitably lead to the company paying a lower dividend in line with lower profits.
In Summary
In summary, while it's always good to see the dividend being raised, we don't think Human Health Holdings' payments are rock solid. The company is generating plenty of cash, which could maintain the dividend for a while, but the track record hasn't been great. This company is not in the top tier of income providing stocks.
Investors generally tend to favour companies with a consistent, stable dividend policy as opposed to those operating an irregular one. Still, investors need to consider a host of other factors, apart from dividend payments, when analysing a company. For example, we've picked out 3 warning signs for Human Health Holdings that investors should know about before committing capital to this stock. Is Human Health Holdings not quite the opportunity you were looking for? Why not check out our selection of top dividend stocks.
Valuation is complex, but we're here to simplify it.
Discover if Human Health Holdings might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SEHK:1419
Human Health Holdings
An investment holding company, provides healthcare services in Hong Kong.
Flawless balance sheet with acceptable track record.
Market Insights
Weekly Picks

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

Fiducian: Compliance Clouds or Value Opportunity?
Willamette Valley Vineyards (WVVI): Not-So-Great Value
Recently Updated Narratives
Halyk Bank of Kazakhstan will see revenue grow 11% as their future PE reaches 3.2x soon
Silver's Breakout to over $50US will make Magma’s future shine with drill sampling returning 115g/t Silver and 2.3 g/t Gold at its Peru Mine
SEGRO's Revenue to Rise 14.7% Amidst Optimistic Growth Plans
Popular Narratives

MicroVision will explode future revenue by 380.37% with a vision towards success

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026
